Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spheroids, Cellular | 5 | 2023 | 329 | 0.530 |
Why?
|
Receptor, erbB-2 | 3 | 2023 | 2554 | 0.450 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 5251 | 0.360 |
Why?
|
Lung Neoplasms | 7 | 2023 | 13262 | 0.320 |
Why?
|
Gene Amplification | 2 | 2023 | 1085 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2018 | 567 | 0.240 |
Why?
|
Cell Line, Tumor | 20 | 2023 | 16939 | 0.220 |
Why?
|
Carbonic Anhydrases | 1 | 2024 | 109 | 0.220 |
Why?
|
Myeloid Progenitor Cells | 1 | 2023 | 114 | 0.220 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2020 | 3584 | 0.210 |
Why?
|
Mutation | 10 | 2023 | 29932 | 0.210 |
Why?
|
Immunity | 2 | 2019 | 998 | 0.210 |
Why?
|
Quinolines | 2 | 2020 | 759 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2023 | 5253 | 0.190 |
Why?
|
Immunotherapy | 3 | 2023 | 4642 | 0.180 |
Why?
|
Receptor, erbB-3 | 1 | 2021 | 143 | 0.180 |
Why?
|
Camptothecin | 1 | 2023 | 590 | 0.170 |
Why?
|
Immune Evasion | 1 | 2023 | 362 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11712 | 0.160 |
Why?
|
Myeloid Cells | 1 | 2023 | 820 | 0.160 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2019 | 192 | 0.160 |
Why?
|
Immunophenotyping | 3 | 2019 | 1871 | 0.150 |
Why?
|
Antineoplastic Agents | 7 | 2021 | 13630 | 0.150 |
Why?
|
Membrane Proteins | 4 | 2022 | 7850 | 0.150 |
Why?
|
Immunoconjugates | 2 | 2023 | 949 | 0.150 |
Why?
|
Mice | 26 | 2024 | 81208 | 0.150 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2023 | 1728 | 0.140 |
Why?
|
Cell Culture Techniques | 3 | 2021 | 1664 | 0.140 |
Why?
|
Neoplasms, Experimental | 1 | 2021 | 1229 | 0.130 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1837 | 0.130 |
Why?
|
Telomere | 2 | 2012 | 933 | 0.120 |
Why?
|
Pyrrolidinones | 1 | 2015 | 116 | 0.120 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6131 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 346 | 0.120 |
Why?
|
Mice, SCID | 1 | 2020 | 2627 | 0.120 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2018 | 432 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 556 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 544 | 0.110 |
Why?
|
Anilides | 1 | 2016 | 409 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2203 | 0.110 |
Why?
|
Huntington Disease | 3 | 2005 | 1141 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 1 | 2022 | 1454 | 0.100 |
Why?
|
Signal Transduction | 8 | 2019 | 23376 | 0.100 |
Why?
|
Animals | 26 | 2024 | 167963 | 0.100 |
Why?
|
Exons | 1 | 2018 | 2388 | 0.100 |
Why?
|
Ovarian Neoplasms | 2 | 2021 | 4878 | 0.100 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2016 | 487 | 0.100 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2012 | 38 | 0.100 |
Why?
|
Pleural Neoplasms | 1 | 2016 | 609 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2012 | 159 | 0.100 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2802 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2018 | 8515 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2668 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 478 | 0.090 |
Why?
|
Mitochondria | 3 | 2011 | 3600 | 0.090 |
Why?
|
Mesothelioma | 1 | 2016 | 807 | 0.090 |
Why?
|
Sunlight | 1 | 2012 | 337 | 0.090 |
Why?
|
DNA-Binding Proteins | 4 | 2013 | 9585 | 0.090 |
Why?
|
Telomerase | 2 | 2012 | 746 | 0.080 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2380 | 0.080 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2016 | 1765 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2020 | 10446 | 0.080 |
Why?
|
Apoptosis | 3 | 2021 | 9501 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3218 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3610 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 568 | 0.080 |
Why?
|
Aneuploidy | 1 | 2012 | 551 | 0.080 |
Why?
|
Protein Kinase Inhibitors | 6 | 2023 | 5643 | 0.080 |
Why?
|
p21-Activated Kinases | 1 | 2008 | 128 | 0.080 |
Why?
|
Nuclear Proteins | 3 | 2007 | 5791 | 0.070 |
Why?
|
rho GTP-Binding Proteins | 1 | 2008 | 277 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4312 | 0.070 |
Why?
|
Melanoma | 2 | 2018 | 5697 | 0.070 |
Why?
|
Pancreatic Ducts | 1 | 2008 | 329 | 0.070 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1313 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5496 | 0.070 |
Why?
|
Mitosis | 1 | 2012 | 1191 | 0.070 |
Why?
|
Chromosomal Instability | 1 | 2007 | 177 | 0.070 |
Why?
|
Chromosome Aberrations | 3 | 2007 | 1764 | 0.070 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 164 | 0.070 |
Why?
|
Wnt Proteins | 1 | 2010 | 719 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 675 | 0.060 |
Why?
|
DNA Repeat Expansion | 1 | 2005 | 72 | 0.060 |
Why?
|
Polyploidy | 1 | 2005 | 119 | 0.060 |
Why?
|
Humans | 35 | 2024 | 760621 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2018 | 4550 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2024 | 10181 | 0.060 |
Why?
|
Lymphoma, T-Cell | 1 | 2007 | 305 | 0.060 |
Why?
|
Pyridines | 1 | 2016 | 2879 | 0.060 |
Why?
|
NF-kappa B | 1 | 2013 | 2488 | 0.060 |
Why?
|
Cytokinesis | 1 | 2005 | 172 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2007 | 1167 | 0.060 |
Why?
|
Neoplasms | 4 | 2019 | 22072 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2012 | 2828 | 0.060 |
Why?
|
Plasma Cells | 1 | 2007 | 591 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2007 | 4407 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-4F | 1 | 2023 | 42 | 0.050 |
Why?
|
Genes, p53 | 1 | 2005 | 713 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2012 | 2919 | 0.050 |
Why?
|
Lysosomes | 2 | 2023 | 920 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2023 | 106 | 0.050 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 1088 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2017 | 2882 | 0.050 |
Why?
|
Multiple Myeloma | 2 | 2013 | 5130 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18137 | 0.050 |
Why?
|
STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
Protein Kinases | 1 | 2009 | 1612 | 0.050 |
Why?
|
Sirolimus | 1 | 2009 | 1547 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2005 | 893 | 0.050 |
Why?
|
Janus Kinases | 1 | 2023 | 250 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2017 | 4902 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4024 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2010 | 11481 | 0.050 |
Why?
|
RNA-Binding Proteins | 1 | 2010 | 1894 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 1132 | 0.050 |
Why?
|
Adenocarcinoma | 1 | 2018 | 6315 | 0.050 |
Why?
|
Calcium Signaling | 1 | 2005 | 732 | 0.050 |
Why?
|
Mice, Transgenic | 5 | 2019 | 9530 | 0.040 |
Why?
|
Caspases | 1 | 2023 | 878 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2895 | 0.040 |
Why?
|
Phthalazines | 1 | 2021 | 383 | 0.040 |
Why?
|
Genome, Human | 1 | 2012 | 4417 | 0.040 |
Why?
|
Energy Metabolism | 2 | 2007 | 2869 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1697 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2023 | 2058 | 0.040 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2021 | 423 | 0.040 |
Why?
|
Cyclic AMP | 1 | 2003 | 1456 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3775 | 0.040 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2018 | 67 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2013 | 9411 | 0.040 |
Why?
|
Transcription Factors | 4 | 2011 | 12103 | 0.040 |
Why?
|
Peptides | 2 | 2007 | 4354 | 0.040 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2018 | 141 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2008 | 1724 | 0.040 |
Why?
|
Quinoxalines | 1 | 2019 | 297 | 0.040 |
Why?
|
Mice, Nude | 3 | 2009 | 3607 | 0.040 |
Why?
|
STAT1 Transcription Factor | 1 | 2018 | 333 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3523 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2016 | 64 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2023 | 1407 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 193 | 0.030 |
Why?
|
Organoids | 1 | 2023 | 729 | 0.030 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2013 | 0.030 |
Why?
|
Gene Knockdown Techniques | 2 | 2013 | 1617 | 0.030 |
Why?
|
Apyrase | 1 | 2018 | 373 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2024 | 1998 | 0.030 |
Why?
|
Antibodies | 1 | 2024 | 2421 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6828 | 0.030 |
Why?
|
Drug Synergism | 1 | 2019 | 1754 | 0.030 |
Why?
|
Glioma | 1 | 2010 | 3420 | 0.030 |
Why?
|
Glioblastoma | 1 | 2010 | 3484 | 0.030 |
Why?
|
Ascites | 1 | 2016 | 338 | 0.030 |
Why?
|
Female | 10 | 2023 | 391270 | 0.030 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2016 | 330 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2023 | 3157 | 0.030 |
Why?
|
CA-125 Antigen | 1 | 2016 | 279 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2864 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2803 | 0.030 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2013 | 193 | 0.030 |
Why?
|
Chromosome Breakpoints | 1 | 2012 | 93 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2018 | 2506 | 0.030 |
Why?
|
Comet Assay | 1 | 2012 | 74 | 0.030 |
Why?
|
Adenosine Triphosphate | 2 | 2011 | 1993 | 0.020 |
Why?
|
DNA Fragmentation | 1 | 2012 | 237 | 0.020 |
Why?
|
Neoplasm Invasiveness | 2 | 2010 | 3618 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1810 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 806 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 4490 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5351 | 0.020 |
Why?
|
Crosses, Genetic | 1 | 2012 | 751 | 0.020 |
Why?
|
Acrylamides | 1 | 2012 | 260 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2012 | 233 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2019 | 2536 | 0.020 |
Why?
|
Cells, Cultured | 4 | 2007 | 18957 | 0.020 |
Why?
|
Gluconeogenesis | 1 | 2011 | 185 | 0.020 |
Why?
|
Cell Survival | 2 | 2013 | 5797 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11071 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6216 | 0.020 |
Why?
|
Genome | 2 | 2007 | 1739 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 1 | 2010 | 458 | 0.020 |
Why?
|
Pyrazoles | 1 | 2019 | 1999 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11345 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2010 | 8986 | 0.020 |
Why?
|
Melanocytes | 1 | 2012 | 512 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2013 | 1387 | 0.020 |
Why?
|
Mutagenesis | 1 | 2012 | 1234 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4000 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6853 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 704 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2448 | 0.020 |
Why?
|
Dromaiidae | 1 | 2007 | 7 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 77 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 869 | 0.020 |
Why?
|
Hypergammaglobulinemia | 1 | 2007 | 72 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2012 | 1078 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5870 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15687 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 295 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9467 | 0.020 |
Why?
|
Oncogenes | 1 | 2012 | 1220 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3844 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 2007 | 1304 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6544 | 0.020 |
Why?
|
Quinazolines | 1 | 2012 | 1363 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 370 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2913 | 0.020 |
Why?
|
Aged | 4 | 2023 | 169152 | 0.020 |
Why?
|
Myoepithelioma | 1 | 2005 | 26 | 0.020 |
Why?
|
Cell Division | 1 | 2013 | 4463 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 22023 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2011 | 858 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1484 | 0.020 |
Why?
|
DNA Replication | 1 | 2012 | 1412 | 0.020 |
Why?
|
Cell Cycle | 1 | 2013 | 2934 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2005 | 429 | 0.010 |
Why?
|
Doxorubicin | 1 | 2011 | 2209 | 0.010 |
Why?
|
Middle Aged | 4 | 2023 | 220352 | 0.010 |
Why?
|
Mammary Glands, Animal | 1 | 2005 | 271 | 0.010 |
Why?
|
Chromones | 1 | 2003 | 149 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4107 | 0.010 |
Why?
|
Cell Transplantation | 1 | 2005 | 472 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3094 | 0.010 |
Why?
|
Phosphorylation | 2 | 2005 | 8313 | 0.010 |
Why?
|
Bone Diseases | 1 | 2007 | 419 | 0.010 |
Why?
|
Alleles | 2 | 2005 | 6898 | 0.010 |
Why?
|
Matrix Metalloproteinases | 1 | 2005 | 392 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10827 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2138 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2003 | 814 | 0.010 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 789 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7343 | 0.010 |
Why?
|
RNA Splicing | 1 | 2007 | 915 | 0.010 |
Why?
|
DNA Damage | 1 | 2012 | 2442 | 0.010 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2003 | 410 | 0.010 |
Why?
|
Cyclin D1 | 1 | 2003 | 451 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2007 | 7593 | 0.010 |
Why?
|
Male | 5 | 2023 | 359744 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2007 | 1115 | 0.010 |
Why?
|
RNA | 1 | 2011 | 2722 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 483 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 491 | 0.010 |
Why?
|
Morpholines | 1 | 2003 | 583 | 0.010 |
Why?
|
Cytosol | 1 | 2003 | 887 | 0.010 |
Why?
|
Immunoblotting | 1 | 2003 | 1649 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2007 | 2698 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 3016 | 0.010 |
Why?
|
Aging | 2 | 2011 | 8651 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2873 | 0.010 |
Why?
|
Serine | 1 | 2003 | 830 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2532 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1952 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29658 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9276 | 0.010 |
Why?
|
Phenotype | 2 | 2008 | 16546 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2011 | 3387 | 0.010 |
Why?
|
Age of Onset | 1 | 2005 | 3301 | 0.010 |
Why?
|
beta Catenin | 1 | 2003 | 1043 | 0.010 |
Why?
|
Skin Diseases | 1 | 2007 | 1089 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2009 | 2698 | 0.010 |
Why?
|
Myocardium | 1 | 2011 | 4700 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1343 | 0.010 |
Why?
|
Adult | 3 | 2017 | 219994 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3602 | 0.010 |
Why?
|
Models, Genetic | 1 | 2007 | 3442 | 0.010 |
Why?
|
Corpus Striatum | 1 | 2003 | 1233 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4713 | 0.010 |
Why?
|
Cell Movement | 1 | 2008 | 5206 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2093 | 0.010 |
Why?
|
Liver | 1 | 2011 | 7509 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4291 | 0.010 |
Why?
|
Cell Membrane | 1 | 2003 | 3682 | 0.010 |
Why?
|
Trans-Activators | 1 | 2003 | 2860 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4742 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3663 | 0.010 |
Why?
|
Genomics | 1 | 2008 | 5794 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 65017 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58995 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11903 | 0.010 |
Why?
|
Neurons | 1 | 2003 | 9426 | 0.000 |
Why?
|
Brain | 1 | 2003 | 26951 | 0.000 |
Why?
|